Short-Term Catheter-Directed Thrombolysis with Low-Dose Urokinase Followed by Aspiration Thrombectomy for Treatment of Symptomatic Lower Extremity Deep Venous Thrombosis

저용량 유로키나제를 이용한 단기간 혈전용해술과 혈전흡입술을 시행한 하지 심부정맥혈전증 환자의 치료 효과

  • Jung, Se-Hee (Department of Radiology, Chonnam National University Hospital) ;
  • Kim, Jae-Kyu (Department of Radiology, Chonnam National University Hospital) ;
  • Chang, Nam-Kyu (Department of Radiology, Chonnam National University Medical School) ;
  • Lim, Jae-Hoon (Department of Radiology, Chonnam National University Hospital) ;
  • Lim, Nam-Yeul (Department of Radiology, Chonnam National University Hospital) ;
  • Song, Jang-Hyeon (Department of Radiology, Chonnam National University Hospital) ;
  • Choi, Soo-Jin-Na (Department of Surgery, Chonnam National University Hospital, Chonnam National University Medical School) ;
  • Chung, Sang-Young (Department of Surgery, Chonnam National University Hospital, Chonnam National University Medical School)
  • 정세희 (전남대학교병원 영상의학과) ;
  • 김재규 (전남대학교병원 영상의학과) ;
  • 장남규 (전남대학교 의과대학 영상의학과학교실) ;
  • 임재훈 (전남대학교병원 영상의학과) ;
  • 임남열 (전남대학교병원 영상의학과) ;
  • 송장현 (전남대학교병원 영상의학과) ;
  • 최수진나 (전남대학교 의과대학 전남대학교병원 외과학교실) ;
  • 정상영 (전남대학교 의과대학 전남대학교병원 외과학교실)
  • Published : 2011.10.01

Abstract

Purpose: To evaluate the venous patency in patients treated by catheter-directed thrombolysis with low-dose urokinase (UK) for symptomatic lower extremity deep venous thrombosis (DVT). Materials and Methods: Eighty-nine consecutive patients (46 women and 43 men; mean age, 58.1 years), treated by catheter-directed thrombolysis with low-dose UK were included in this study. Immediate venous patency was evaluated in terms of technical success (successful restoration of antegrade in-line flow in the treated vein with residual stenosis rate of less than 30%) and clinical success (significant reduction of clinical symptoms before hospital discharge). Late venous patency was evaluated in terms of primary patency rate and clinical success. Results: Immediate technical success was achieved in all patients and immediate clinical success in 80 (90%) patients. There was no major systemic bleeding complication. The primary patency rate at 6 months and 12 months was 84% and 79%, respectively. Fifty-six (63%) patients were asymptomatic after a median clinical follow-up of 18 months, eleven (12%) patients improved moderately, seven (8%) patients remained unchanged, and fifteen (17%) patients had no clinical follow-up. Conclusion: Short-term catheter-directed thrombolysis with low-dose UK can be an effective, safe method to manage DVT of the lower extremities.

목적: 저용량 유로키나제를 이용하여 단기간 혈전용해술을 시행한 유증상 하지 심부정맥혈전증 환자의 정맥 개통성에 대해 알아본다. 대상과 방법: 2006년 1월부터 2010년 4월까지 저용량 유로키나제를 이용하여 혈전용해술을 시행한 89명을 대상으로 하였다. 즉각 정맥 개통성은 기술적인 측면과 임상적인 측면에서 평가하였고 후기 정맥 개통성은 일차 혈관 개통률 측면과 임상적인 측면에서 평가하였다. 일차 혈관 개통률은 시술 6개월과 12개월 이후에 정맥혈관조영술을 시행한 환자를 대상으로 하였다. 결과: 즉각적인 기술적 및 임상적 성공률은 각각 100%, 90%이며 시술 중 또는 시술 직후에 발생한 주요 합병증은 없었다. 추적기간 동안에 6개월과 12개월의 일차 혈관 개통률은 각각 84%와 79%였다. 18개월의 중앙추적기간 동안 무증상은 63%, 중등도의 증상 개선은 12%, 변화 없는 경우는 8%였으며 17%의 환자가 임상적으로 추적 관찰되지 않았다. 결론: 저용량 유로키나제를 이용한 단기간 혈전용해술은 하지 심부정맥혈전증의 치료에 효과적이고 안전한 치료방법이다.

Keywords

References

  1. Comerota AJ, Throm RC, Mathias SD, Haughton S, Mewissen M. Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life. J Vasc Surg 2000;32:130-137 https://doi.org/10.1067/mva.2000.105664
  2. Patel NH, Stookey KR, Ketcham DB, Cragg AH. Endovascular management of acute extensive iliofemoral deep venous thrombosis caused by May-Thurner syndrome. J Vasc Interv Radiol 2000;11:1297-1302 https://doi.org/10.1016/S1051-0443(07)61304-9
  3. Ouriel K, Katzen B, Mewissen M, Flick P, Clair DG, Benenati J, et al. Reteplase in the treatment of peripheral arterial and venous occlusions: a pilot study. J Vasc Interv Radiol 2000;11:849-854 https://doi.org/10.1016/S1051-0443(07)61799-0
  4. Delomez M, Beregi JP, Willoteaux S, Bauchart JJ, Janne d'Othee B, Asseman P, et al. Mechanical thrombectomy in patients with deep venous thrombosis. Cardiovasc Intervent Radiol 2001;24:42-48 https://doi.org/10.1007/s002700001658
  5. Gandini R, Maspes F, Sodani G, Masala S, Assegnati G, Simonetti G. Percutaneous ilio-caval thrombectomy with the Amplatz device: preliminary results. Eur Radiol 1999; 9:951-958 https://doi.org/10.1007/s003300050775
  6. Vedantham S, Grassi CJ, Ferral H, Patel NH, Thorpe PE, Antonacci VP, et al. Reporting standards for endovascular treatment of lower extremity deep vein thrombosis. J Vasc Interv Radiol 2009;20:S391-S408 https://doi.org/10.1016/j.jvir.2009.04.034
  7. Sacks D, Marinelli DL, Martin LG, Spies JB; Society of Interventional Radiology Technology Assessment Committee. Reporting standards for clinical evaluation of new peripheral arterial revascularization devices. J Vasc Interv Radiol 2003;14:S395-S404 https://doi.org/10.1097/01.RVI.0000094613.61428.a9
  8. Vedantham S, Vesely TM, Sicard GA, Brown D, Rubin B, Sanchez LA, et al. Pharmacomechanical thrombolysis and early stent placement for iliofemoral deep vein thrombosis. J Vasc Interv Radiol 2004;15:565-574 https://doi.org/10.1097/01.RVI.0000127894.00553.02
  9. Grossman C, McPherson S. Safety and efficacy of catheter-directed thrombolysis for iliofemoral venous thrombosis. AJR Am J Roentgenol 1999;172:667-672 https://doi.org/10.2214/ajr.172.3.10063857
  10. O'Sullivan GJ, Semba CP, Bittner CA, Kee ST, Razavi MK, Sze DY, et al. Endovascular management of iliac vein compression (May-Thurner) syndrome. J Vasc Interv Radiol 2000;11:823-836 https://doi.org/10.1016/S1051-0443(07)61796-5
  11. Jang MJ, Bang SM, Oh D. Incidence of venous thromboembolism in Korea: from the Health Insurance Review and Assessment Service database. J Thromb Haemost 2011;9: 85-91 https://doi.org/10.1111/j.1538-7836.2010.04108.x
  12. Akesson H, Brudin L, Dahlstrom JA, Eklof B, Ohlin P, Plate G. Venous function assessed during a 5 year period after acute ilio-femoral venous thrombosis treated with anticoagulation. Eur J Vasc Surg 1990;4:43-48 https://doi.org/10.1016/S0950-821X(05)80037-4
  13. Johnson BF, Manzo RA, Bergelin RO, Strandness DE Jr. Relationship between changes in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein thrombosis: a one- to six-year follow-up. J Vasc Surg 1995;21:307-312; discussion 313 https://doi.org/10.1016/S0741-5214(95)70271-7
  14. Elsharawy M, Elzayat E. Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis. A randomised clinical trial. Eur J Vasc Endovasc Surg 2002;24: 209-214 https://doi.org/10.1053/ejvs.2002.1665
  15. Mewissen MW, Seabrook GR, Meissner MH, Cynamon J, Labropoulos N, Haughton SH. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology 1999; 211:39-49
  16. Bjarnason H, Kruse JR, Asinger DA, Nazarian GK, Dietz CA Jr, Caldwell MD, et al. Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy. J Vasc Interv Radiol 1997;8: 405-418 https://doi.org/10.1016/S1051-0443(97)70581-5
  17. Kasirajan K, Gray B, Ouriel K. Percutaneous AngioJet thrombectomy in the management of extensive deep venous thrombosis. J Vasc Interv Radiol 2001;12:179-185 https://doi.org/10.1016/S1051-0443(07)61823-5
  18. Suh SH, Lee DY, Won JY. Endovascular treatment of left iliofemoral deep vein thrombosis using urokinase thrombolysis and adjunctive aspiration thrombectomy. J Korean Soc Radiol 2010;63:19-28 https://doi.org/10.3348/jksr.2010.63.1.19